Tandem Diabetes Care | TNDM - Market Capitalization


Tandem Diabetes Care reported $1.27B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 178.41B 39.46B Mar/2026
Align Technology USD 12.28B 1.07B Mar/2026
AtriCure USD 1.43B 12M May/2026
Baxter International USD 8.67B 1.15B Mar/2026
Becton, Dickinson and Co. USD 55.29B 1.64B Dec/2025
Boston Scientific USD 93.26B 48.09B Mar/2026
Cooper Companies USD 15.95B 2.05B Dec/2025
Dexcom USD 24.17B 1.72B Mar/2026
Edwards Lifesciences USD 46.17B 3.3B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Globus Medical USD 11.69B 3.95B Dec/2025
ICU Medical USD 3.52B 561M Dec/2025
Insulet USD 10.58B 3.96B May/2026
Integra LifeSciences USD 1.03B 301M May/2026
Intuitive Surgical USD 163.73B 37.04B Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Masimo USD 6.84B 839M Dec/2025
Merit Medical Systems USD 4.11B 1.11B Mar/2026
Orthofix International USD 604M 25M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Stryker USD 125.85B 8.57B Mar/2026
Tandem Diabetes Care USD 1.49B 670M Dec/2025
Teleflex USD 5.39B 91M Dec/2025
Zimmer Biomet Holdings USD 17.5B 321M Mar/2026